The Sotos Syndrome Gene Panel uses advanced Next-Generation Sequencing (NGS) to detect mutations linked to Sotos syndrome, a genetic condition characterized by overgrowth and developmental delays. Metropolis Healthcare analyzes an EDTA blood sample to identify pathogenic variants responsible for the disorder. This test enables early and accurate diagnosis, helping clinicians plan appropriate developmental and medical interventions. It also provides essential information for genetic counseling and long-term care planning.
Price:
Rs. 21,000.00
Sample Type: EDTA BLOOD
Fasting Not Required
Booking Procedure:
- Technician from Metropolis will be assigned for a home sample collection after booking confirmation.
- Sample will be collected by our technician at your address at given slot.
- You can make the payment to the technician at the time of collection
- Your sample will then be transported to the nearest collection center and will be centrifuged before sending to the lab for processing.
- Soft copy reports will be sent to your email address within 24 to 48 hours or as per defined TAT for Tests.
Frequently Asked Questions (FAQ's):
What does the Sotos Syndrome Gene Panel include?
This panel at Metropolis Healthcare includes NGS-based analysis of key genes associated with Sotos syndrome and related overgrowth conditions.
How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses high-depth sequencing platforms to detect mutations such as single-nucleotide variants, deletions, and insertions.
Who should take this test?
Children or individuals with overgrowth, distinctive facial features, developmental delays, or suspected Sotos syndrome should consider testing at Metropolis Healthcare.
Why is this test important?
It helps confirm a genetic diagnosis, guiding developmental support and clinical management through Metropolis Healthcare’s advanced diagnostics.
What sample is required for the test?
An EDTA blood sample is used for DNA extraction and NGS analysis at Metropolis Healthcare.
Can this test assist in treatment planning?
Yes, results from Metropolis Healthcare aid clinicians in tailoring early interventions and monitoring developmental progress.
Is this test suitable for infants?
Yes, Metropolis Healthcare performs this test for infants and children showing early signs of overgrowth or developmental concerns.
Do the results support genetic counseling?
Absolutely. Metropolis Healthcare provides detailed reports that help families understand inheritance risks and future planning.